These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25273687)

  • 1. Ipilimumab and whole brain radiation therapy for melanoma brain metastases.
    Gerber NK; Young RJ; Barker CA; Wolchok JD; Chan TA; Yamada Y; Friguglietti L; Beal K
    J Neurooncol; 2015 Jan; 121(1):159-65. PubMed ID: 25273687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
    Williams NL; Wuthrick EJ; Kim H; Palmer JD; Garg S; Eldredge-Hindy H; Daskalakis C; Feeney KJ; Mastrangelo MJ; Kim LJ; Sato T; Kendra KL; Olencki T; Liebner DA; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Dicker AP; Werner-Wasik M; Shi W
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):22-30. PubMed ID: 28816150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.
    Knisely JP; Yu JB; Flanigan J; Sznol M; Kluger HM; Chiang VL
    J Neurosurg; 2012 Aug; 117(2):227-33. PubMed ID: 22702482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
    Weber JS; Amin A; Minor D; Siegel J; Berman D; O'Day SJ
    Melanoma Res; 2011 Dec; 21(6):530-4. PubMed ID: 22051508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.
    Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK
    Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
    Margolin K; Ernstoff MS; Hamid O; Lawrence D; McDermott D; Puzanov I; Wolchok JD; Clark JI; Sznol M; Logan TF; Richards J; Michener T; Balogh A; Heller KN; Hodi FS
    Lancet Oncol; 2012 May; 13(5):459-65. PubMed ID: 22456429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.
    Jones PS; Cahill DP; Brastianos PK; Flaherty KT; Curry WT
    Neurosurg Focus; 2015 Mar; 38(3):E5. PubMed ID: 25727227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipilimumab and radiation therapy for melanoma brain metastases.
    Silk AW; Bassetti MF; West BT; Tsien CI; Lao CD
    Cancer Med; 2013 Dec; 2(6):899-906. PubMed ID: 24403263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery.
    Tazi K; Hathaway A; Chiuzan C; Shirai K
    Cancer Med; 2015 Jan; 4(1):1-6. PubMed ID: 25164960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
    Konstantinou MP; Dutriaux C; Gaudy-Marqueste C; Mortier L; Bedane C; Girard C; Thellier S; Jouary T; Grob JJ; Richard MA; Templier C; Sakji L; Guillot B; Paul C; Meyer N
    Acta Derm Venereol; 2014 Jan; 94(1):45-9. PubMed ID: 23824275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.
    Gupta A; Roberts C; Tysoe F; Goff M; Nobes J; Lester J; Marshall E; Corner C; Wolstenholme V; Kelly C; Wise A; Collins L; Love S; Woodward M; Salisbury A; Middleton MR
    Br J Cancer; 2016 Nov; 115(10):1193-1200. PubMed ID: 27711083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-brain radiotherapy in patients with brain metastases from melanoma.
    de la Fuente M; Beal K; Carvajal R; Kaley TJ
    CNS Oncol; 2014 Nov; 3(6):401-6. PubMed ID: 25438811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
    Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A
    Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.
    Kiess AP; Wolchok JD; Barker CA; Postow MA; Tabar V; Huse JT; Chan TA; Yamada Y; Beal K
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):368-75. PubMed ID: 25754629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.
    Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A
    Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
    Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K
    J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases.
    Queirolo P; Spagnolo F; Ascierto PA; Simeone E; Marchetti P; Scoppola A; Del Vecchio M; Di Guardo L; Maio M; Di Giacomo AM; Antonuzzo A; Cognetti F; Ferraresi V; Ridolfi L; Guidoboni M; Guida M; Pigozzo J; Chiarion Sileni V
    J Neurooncol; 2014 May; 118(1):109-16. PubMed ID: 24532241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipilimumab and Bevacizumab in Glioblastoma.
    Carter T; Shaw H; Cohn-Brown D; Chester K; Mulholland P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):622-626. PubMed ID: 27169593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
    Long GV; Atkinson V; Cebon JS; Jameson MB; Fitzharris BM; McNeil CM; Hill AG; Ribas A; Atkins MB; Thompson JA; Hwu WJ; Hodi FS; Menzies AM; Guminski AD; Kefford R; Kong BY; Tamjid B; Srivastava A; Lomax AJ; Islam M; Shu X; Ebbinghaus S; Ibrahim N; Carlino MS
    Lancet Oncol; 2017 Sep; 18(9):1202-1210. PubMed ID: 28729151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.